Jong-Wan Park
Cancer Research · 2002–2010
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 15 citations into it
Whom Jong-Wan Park trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Semenza (in Cancer Research)
Papers from Jong-Wan Park's perspective
Ordered by how strongly the researchers Jong-Wan Park trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. (Genes & Development)
- HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. (Cell Metabolism)
- Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. (Science)
- Oxygen sensing by HIF hydroxylases (Nature reviews. Molecular cell biology)
- Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
- The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth (PLoS ONE)
- HIF-1 and tumor progression: pathophysiology and therapeutics. (Trends in Molecular Medicine)
- HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. (Cell)
- FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. (Genes & Development)
Their papers
- Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. (2010) — 781 citations
- Jab1 Interacts Directly with HIF-1α and Regulates Its Stability* (2002) — 178 citations